Company Profile

Jenesis Biosciences LLC
Profile last edited on: 1/29/2024      CAGE: 6FVP5      UEI: ----------

Business Identifier: Diabetes-related technologies
Year Founded
2011
First Award
2014
Latest Award
2014
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

One Joslin Place
Boston, MA 02215
   (617) 309-2400
   info@jenesisbiosciences.org
   www.jenesisbio.com
Location: Single
Congr. District: 07
County: Suffolk

Public Profile

Jenesis Biosciences LLC is exploring novel technologies in molecular targets for treatment of diabetes complications, biomarkers for risk of disease and response to treatments in diabetes, and beta cell markers of growth and maturation. The company has a pipeline of platform technologies that will identify and develop targets for treatment of diabetes and complications. Several key areas of markers are currently being developed and validated in collaboration with Joslin: * Treatment of complications, * Molecular Factors in Exercise-mediated Benefit in Diabetes, * Beta cell development and maturation.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 1 NIH $150,000
Project Title: Developing Inhibitors of the STARS/SRF Pathway for Treatment of Type 2 Diabetes

Key People / Management

  Nandan Padukone -- Acting CEO and Managing Member

Company News

There are no news available.